Moffitt Cancer Center to be Featured at the American Society of Clinical Pathology’s Annual Meeting

October 06, 2014

WHO: Moffitt Cancer Center, the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, and the American Society of Clinical Pathology (ASCP) will present “Moffitt Cancer Center: Boundless opportunities in pathology, research and education.”

WHAT: The presentation will take place during the opening reception of the ASCP’s annual meeting being held at the Tampa Convention Center. Each year the meeting hosts 1,500 pathologists, medical residents and laboratory professionals.

Moffitt’s opening presentation will feature Moffitt’s Chair of Hematopathology and Laboratory Medicine, Lynn Moscinski, M.D., and Chair of Anatomic Pathology and Executive Director of the Morsani Molecular Diagnostic Laboratory, Anthony Magliocco, M.D..

Throughout the conference Moffitt will showcase various clinical, research and educational projects at an exhibition booth. Additionally, Moffitt staff will present various findings related to pathology and healthcare.

WHEN: Opening Reception, 6:45 – 7:30 p.m. Wednesday, October 8.

WHERE: Tampa Convention Center, 333 South Franklin Street Tampa, Florida 33602

CONTACT:    For a full schedule of presentations and events and for more information about the conference visit the American Society of Clinical Pathology’s annual meeting website, 2014 Tampa Beyond the Lab.

About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in the Southeast and has been listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer since 1999. With more than 4,500 employees, Moffitt has an economic impact on the state of nearly $1.6 billion. For more information, visit, and follow the Moffitt momentum on Facebook, Twitter and YouTube.